rs150900695

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_003159.3(CDKL5):​c.2994C>T​(p.Phe998Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00043 in 1,209,395 control chromosomes in the GnomAD database, including 3 homozygotes. There are 124 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., 65 hem., cov: 23)
Exomes 𝑓: 0.00025 ( 2 hom. 59 hem. )

Consequence

CDKL5
NM_003159.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.119

Publications

2 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
RS1 Gene-Disease associations (from GenCC):
  • retinoschisis
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • X-linked retinoschisis
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant X-18653445-C-T is Benign according to our data. Variant chrX-18653445-C-T is described in ClinVar as Benign. ClinVar VariationId is 136716.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.119 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00223 (249/111722) while in subpopulation AFR AF = 0.00738 (227/30742). AF 95% confidence interval is 0.0066. There are 1 homozygotes in GnomAd4. There are 65 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 249 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003159.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RS1
NM_000330.4
MANE Select
c.184+3208G>A
intron
N/ANP_000321.1O15537
CDKL5
NM_001037343.2
c.2994C>Tp.Phe998Phe
synonymous
Exon 22 of 22NP_001032420.1O76039-1
CDKL5
NM_003159.3
c.2994C>Tp.Phe998Phe
synonymous
Exon 21 of 21NP_003150.1O76039-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKL5
ENST00000379989.6
TSL:1
c.2994C>Tp.Phe998Phe
synonymous
Exon 22 of 22ENSP00000369325.3O76039-1
CDKL5
ENST00000379996.7
TSL:1
c.2994C>Tp.Phe998Phe
synonymous
Exon 21 of 21ENSP00000369332.3O76039-1
RS1
ENST00000379984.4
TSL:1 MANE Select
c.184+3208G>A
intron
N/AENSP00000369320.3O15537

Frequencies

GnomAD3 genomes
AF:
0.00223
AC:
249
AN:
111670
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00740
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00162
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00201
GnomAD2 exomes
AF:
0.000577
AC:
105
AN:
181879
AF XY:
0.000406
show subpopulations
Gnomad AFR exome
AF:
0.00736
Gnomad AMR exome
AF:
0.000256
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000247
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000247
AC:
271
AN:
1097673
Hom.:
2
Cov.:
31
AF XY:
0.000162
AC XY:
59
AN XY:
363083
show subpopulations
African (AFR)
AF:
0.00762
AC:
201
AN:
26389
American (AMR)
AF:
0.000341
AC:
12
AN:
35184
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19378
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30189
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
54053
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40426
Middle Eastern (MID)
AF:
0.000743
AC:
3
AN:
4039
European-Non Finnish (NFE)
AF:
0.0000166
AC:
14
AN:
841955
Other (OTH)
AF:
0.000760
AC:
35
AN:
46060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00223
AC:
249
AN:
111722
Hom.:
1
Cov.:
23
AF XY:
0.00192
AC XY:
65
AN XY:
33896
show subpopulations
African (AFR)
AF:
0.00738
AC:
227
AN:
30742
American (AMR)
AF:
0.00162
AC:
17
AN:
10504
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3525
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2679
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6021
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53187
Other (OTH)
AF:
0.00198
AC:
3
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00109
Hom.:
4
Bravo
AF:
0.00245

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Developmental and epileptic encephalopathy, 2 (1)
-
-
1
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like (1)
-
-
1
History of neurodevelopmental disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.0
DANN
Benign
0.59
PhyloP100
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150900695; hg19: chrX-18671565; COSMIC: COSV66106493; COSMIC: COSV66106493; API